Recent Quotes (30 days)

You have no recent quotes
chg | %

Titan Medical Inc.  

(Public, CVE:TMD)   Watch this stock  
Find more results for TMD
Sep 29 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.38 - 2.76
Open     -
Vol / Avg. 0.00/48,846.00
Mkt cap 249.34M
P/E     -
Div/yield     -
EPS -0.20
Shares 101.80M
Beta 0.05
Inst. own     -
Aug 9, 2016
Q2 2016 Titan Medical Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
May 16, 2016
Q1 2016 Titan Medical Inc Earnings Call - Webcast
May 16, 2016
Q1 2016 Titan Medical Inc Earnings Release
Mar 30, 2016
Q4 2015 Titan Medical Inc Earnings Release

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -340.24% -171.57%
Return on average equity -3212.90% -283.52%
Employees 7 -
CDP Score - -


170 University Ave Suite 1000
+1-416-5487522 (Phone)

Website links


Titan Medical Inc. is a Canada-based development-stage company. The Company focuses on the research and development of robotic surgical technologies for application in minimally invasive surgery (MIS). It is engaged in developing the SPORT (Single Port Orifice Robotic Technology) Surgical System, which is a single-incision (also referred to as single-port) robotic surgical system. The Company's SPORT Surgical System comprises a surgeon-controlled robotic platform that includes a three dimensional (3D) vision system and multi-articulating instruments for performing MIS procedures, and a surgeon workstation that provides the surgeon with an interface to the robotic platform and also provides a 3D endoscopic view of inside a patient's body cavity during MIS procedures. In addition to development of robotic surgical technologies, the Company also focuses on exploring in-licensing opportunities for technologies that may be used in conjunction with the Company's surgical system.

Officers and directors

John T. Hargrove Chairman of the Board, Chief Executive Officer
Reiza Rayman M.D. President, Director
Age: 51
Stephen D. Randall Chief Financial Officer, Secretary
Dennis L. Fowler Executive Vice President - Clinical and Regulatory Affairs
John E. Barker Independent Director
Age: 67
Martin C. Bernholtz Independent Director
Bruce Gilles Wolff M.D. Independent Director